BNP Paribas Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $59.6M | Buy |
180,012
+70,408
| +64% | +$24M | 0.07% | 274 |
|
|
2025
Q4 | $43.6M | Buy |
109,604
+77,235
| +239% | +$34.2M | 0.05% | 337 |
|
|
2025
Q3 | $14.8M | Buy |
32,369
+967
| +3% | +$394K | 0.04% | 388 |
|
|
2025
Q2 | $10.2M | Buy |
31,402
+15,569
| +98% | +$4.31M | 0.03% | 456 |
|
|
2025
Q1 | $4.29M | Buy |
15,833
+3,784
| +31% | +$972K | 0.01% | 575 |
|
|
2024
Q4 | $2.83M | Buy |
12,049
+6,678
| +124% | +$1.76M | 0.01% | 656 |
|
|
2024
Q3 | $1.48M | Sell |
5,371
-703
| -12% | -$183K | ﹤0.01% | 712 |
|
|
2024
Q2 | $1.48M | Sell |
6,074
-556
| -8% | -$87.8K | ﹤0.01% | 722 |
|
|
2024
Q1 | $991K | Sell |
6,630
-118,749
| -95% | -$19.8M | ﹤0.01% | 745 |
|
|
2023
Q4 | $24M | Buy |
125,379
+12,249
| +11% | +$2.09M | 0.07% | 275 |
|
|
2023
Q3 | $20M | Buy |
113,130
+11,588
| +11% | +$2.21M | 0.06% | 290 |
|
|
2023
Q2 | $19.3M | Sell |
101,542
-13,353
| -12% | -$2.65M | 0.06% | 293 |
|
|
2023
Q1 | $23M | Sell |
114,895
-11,952
| -9% | -$2.51M | 0.08% | 264 |
|
|
2022
Q4 | $30.1M | Buy |
126,847
+61,583
| +94% | +$13.1M | 0.11% | 220 |
|
|
2022
Q3 | $13.1M | Buy |
65,264
+11,893
| +22% | +$2.27M | 0.05% | 370 |
|
|
2022
Q2 | $7.78M | Buy |
53,371
+8,992
| +20% | +$1.28M | 0.03% | 445 |
|
|
2022
Q1 | $7.25M | Buy |
44,379
+43,121
| +3,428% | +$6.57M | 0.03% | 471 |
|
|
2021
Q4 | $213K | Sell |
1,258
-56,992
| -98% | -$10.6M | ﹤0.01% | 898 |
|
|
2021
Q3 | $11M | Buy |
58,250
+6,595
| +13% | +$1.24M | 0.04% | 397 |
|
|
2021
Q2 | $8.76M | Sell |
51,655
-24,006
| -32% | -$3.52M | 0.03% | 456 |
|
|
2021
Q1 | $10.7M | Buy |
75,661
+14,714
| +24% | +$2.21M | 0.04% | 402 |
|
|
2020
Q4 | $7.92M | Buy |
60,947
+10,087
| +20% | +$1.35M | 0.04% | 417 |
|
|
2020
Q3 | $7.41M | Buy |
50,860
+2,797
| +6% | +$397K | 0.04% | 372 |
|
|
2020
Q2 | $7.12M | Sell |
48,063
-6,315
| -12% | -$851K | 0.05% | 365 |
|
|
2020
Q1 | $5.92M | Buy |
+54,378
| New | +$6.28M | 0.05% | 358 |
|
|
2019
Q4 | – | Sell |
-2,502
| Closed | -$201K | – | 823 |
|
|
2019
Q3 | $201K | Buy |
+2,502
| New | +$198K | ﹤0.01% | 837 |
|
|
2016
Q4 | – | Sell |
-3,133
| Closed | -$212K | – | 980 |
|
|
2016
Q3 | $212K | Buy |
+3,133
| New | +$221K | ﹤0.01% | 1064 |
|
|
2016
Q1 | – | Sell |
-25,094
| Closed | -$2.36M | – | 1067 |
|
|
2015
Q4 | $2.36M | Buy |
25,094
+1,939
| +8% | +$180K | 0.02% | 629 |
|
|
2015
Q3 | $1.86M | Sell |
23,155
-24,465
| -51% | -$2.72M | 0.02% | 692 |
|
|
2015
Q2 | $5.71M | Sell |
47,620
-20,510
| -30% | -$2.45M | 0.05% | 464 |
|
|
2015
Q1 | $7.11M | Sell |
68,130
-100,598
| -60% | -$10.2M | 0.05% | 390 |
|
|
2014
Q4 | $16.4M | Sell |
168,728
-50,856
| -23% | -$4.71M | 0.13% | 208 |
|
|
2014
Q3 | $17.1M | Buy |
219,584
+19,145
| +10% | +$1.23M | 0.14% | 195 |
|
|
2014
Q2 | $12.7M | Buy |
200,439
+61,479
| +44% | +$3.65M | 0.1% | 254 |
|
|
2014
Q1 | $9.33M | Buy |
138,960
+41,738
| +43% | +$3.23M | 0.07% | 297 |
|
|
2013
Q4 | $6.25M | Buy |
97,222
+22,904
| +31% | +$1.37M | 0.05% | 355 |
|
|
2013
Q3 | $4.76M | Sell |
74,318
-78,666
| -51% | -$3.92M | 0.04% | 383 |
|
|
2013
Q2 | $4.74M | Buy |
+152,984
| New | +$4.07M | 0.04% | 417 |
|
Other funds holding ALNY
VPM
VCM
